Serum free light chain level increase precedes amyloidosis

Serum free light chain level increase precedes amyloidosis
Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis, according to a study published online July 14 in the Journal of Clinical Oncology.

(HealthDay)—Increased serum free light chains (FLCs) precede the presentation of immunoglobulin light chain amyloidosis (AL amyloidosis), according to a study published online July 14 in the Journal of Clinical Oncology.

To characterize monoclonal immunoglobulin (M-Ig) light chains before clinical presentation of AL , Brendan M. Weiss, M.D., from the University of Pennsylvania in Philadelphia, and colleagues evaluated prediagnostic sera from 20 cases with AL amyloidosis and 20 healthy controls matched for age, sex, race, and age of serum sample. They performed serum protein electrophoresis with immunofixation and FLC analysis on all samples.

The researchers detected M-Ig in 100 percent of cases and none of the controls (P < 0.001). Detectable M-Ig was seen in 100 percent of cases at less than four years before diagnosis; 80 percent of cases at four to 11 years; and 42 percent of cases more than 11 years before diagnosis. At all time periods, the median FLC differential (FLC-diff) was higher in cases than controls. A FLC-diff >23 mg/L was seen in 85 percent of cases and no controls (P < 0.001). In 84 percent of cases and 16 percent of controls, the FLC-diff level increased more than 10 percent per year (P < 0.001).

"Increase of FLCs, including within the accepted normal range, precedes the development of AL amyloidosis for many years," the authors write.


Explore further

Free light chains identified in chronic rhinosinusitis

More information: Abstract
Full Text (subscription or payment may be required)
Editorial
Journal information: Journal of Clinical Oncology

Copyright © 2014 HealthDay. All rights reserved.

Citation: Serum free light chain level increase precedes amyloidosis (2014, July 25) retrieved 13 November 2019 from https://medicalxpress.com/news/2014-07-serum-free-chain-amyloidosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments